Desmoid Tumor Completed Phase 2 Trials for Sunitinib (DB01268)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00474994Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasTreatment